Report cover image

Rituxan Market, By Indication (Non-Hodgkins Lymphoma (NHL), Mature B-cell Non-Hodgkins Lymphoma, Mature B-cell Acute Leukemia, Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiit

Published Jun 19, 2025
Length 165 Pages
SKU # CMI20173682

Description

The global Rituxan market, valued at USD 1,584.3 Mn in 2025, is expected to decline steadily to USD 1,082.1 Mn by 2032, exhibiting a negative compound annual growth rate (CAGR) of -5.3% from 2025 to 2032. While Rituxan, a monoclonal antibody targeting CD20 proteins on B-cells, has transformed the treatment of autoimmune disorders and hematological malignancies like rheumatoid arthritis, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia, the market is facing challenges. The expiration of patents and increasing competition from biosimilars are expected to significantly affect the market share of Rituxan during the forecast period.

Market Dynamic

The decline in Rituxan's market is primarily attributed to the rising competition from biosimilars, which offer more affordable alternatives. Despite the drug's successful use in chronic conditions, the high cost of treatment remains a key constraint. Additionally, the potential side effects of Rituxan and the growing number of treatment options are likely to limit its use. However, opportunities exist in expanding Rituxan's indications for diseases such as multiple sclerosis and other autoimmune disorders, alongside new formulations and delivery methods like subcutaneous administration, which could improve patient convenience and mitigate some of the market's challenges.

Key Features of the Study
  • This report provides in-depth analysis of the global Rituxan market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Rituxan market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key company covered as a part of this study include Genentech (Part of Roche), Biogen, Chugai Pharmaceutical Co., Ltd., and ZENYAKU KOGYO CO., LTD.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Rituxan market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rituxan market
Market Segmentation
  • Indication Insights (Revenue, USD Mn, 2020 - 2032)
  • Non-Hodgkin’s Lymphoma (NHL)
  • Mature B-cell Non-Hodgkin’s Lymphoma
  • Mature B-cell Acute Leukemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Rheumatoid Arthritis (RA)
  • Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
  • Pemphigus Vulgaris (PV)
  • Dosage Forms and Strength Insights (Revenue, USD Mn, 2020 - 2032)
  • 100 mg/10 mL (single-use vial)
  • 500 mg/50 mL (single-use vial)
  • Patient Age Group Insights (Revenue, USD Mn, 2020 - 2032)
  • Pediatric
  • Adult
  • Geriatric
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Oncology Centers
  • Infusion Centers
  • Ambulatory Surgical Centers
  • Others (Specialty Clinics, etc.)
  • Sales Channel Insights (Revenue, USD Mn, 2020 - 2032)
  • Online
  • Offline
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Genentech (Part of Roche)
  • Biogen
  • Chugai Pharmaceutical Co., Ltd.
  • ZENYAKU KOGYO CO., LTD

Table of Contents

165 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Rituxan Market, By Indication
Global Rituxan Market, By Dosage Forms and Strength
Global Rituxan Market, By Patient Age Group
Global Rituxan Market, By End User
Global Rituxan Market, By Sales Channel
Global Rituxan Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
Reimbursement Scenario
Epidemiology
Pricing Analysis
4. Global Rituxan Market, By Indication, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Non-Hodgkin’s Lymphoma (NHL)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mature B-cell Non-Hodgkin’s Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mature B-cell Acute Leukemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Chronic Lymphocytic Leukemia (CLL)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Rheumatoid Arthritis (RA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Pemphigus Vulgaris (PV)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Rituxan Market, By Dosage Forms and Strength, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
100 mg/10 mL (single-use vial)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
500 mg/50 mL (single-use vial)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Rituxan Market, By Patient Age Group, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Rituxan Market, By End User, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Oncology Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infusion Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Specialty Clinics, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Rituxan Market, By Sales Channel, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Online
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Offline
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Rituxan Market, By Region, 2020 - 2032, Value (USD Mn)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Dosage Forms and Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Dosage Forms and Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Dosage Forms and Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Dosage Forms and Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Dosage Forms and Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Dosage Forms and Strength, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Sales Channel, 2020 - 2032, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Genentech (Part of Roche)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Biogen
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Chugai Pharmaceutical Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ZENYAKU KOGYO CO., LTD
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on ‘Rituxan Market' - Global forecast to 2032
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.